Novartis AG said its Gilenya drug to treat multiple sclerosis helped slow brain loss, a measure linked to the severity of the disease.
Patients taking Gilenya in three large Novartis-led studies lost a third less brain volume than patients taking either a placebo or Biogen Idec Inc. Avonex, Novartis said in an e- mailed statement today..... Read More - http://www.ms-uk.org/index.cfm/gilenya
Oral MS drug, Gilenya, Slowed Brain Loss in Study
Oral MS drug, Gilenya, Slowed Brain Loss in Study
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1343 Views
-
Last post by frodo
-
- 1 Replies
- 410 Views
-
Last post by NHE
-
- 1 Replies
- 1059 Views
-
Last post by Petr75
-
- 5 Replies
- 13271 Views
-
Last post by gibbledygook
-
- 2 Replies
- 2073 Views
-
Last post by NHE
-
- 0 Replies
- 464 Views
-
Last post by NHE
-
- 0 Replies
- 1425 Views
-
Last post by NHE
-
- 0 Replies
- 1637 Views
-
Last post by frodo
-
- 6 Replies
- 3316 Views
-
Last post by NHE